Science13 hours ago
Spero Therapeutics and GSK Report Promising Phase 3 Results for Tebipenem HBr
Spero Therapeutics, Inc. and GSK plc have announced promising results from the pivotal Phase 3 PIVOT-PO trial for **tebipenem HBr**, an investigational oral antibiotic aimed at...
